Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Rosuvastatin Calcium Market Delivering High growth in the forecast period (2015-2023) | Research Cosmos

 



(Medical-NewsWire.com, March 12, 2018 ) Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).Rosuvastatin Calcium is a member of the drug class of statins, used in combination with exercise, diet, and weight-loss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Rosuvastatin Calcium was developed by Shionogi and has been formulated into finished oral dosage form and marketedby AstraZeneca as Crestor, Abbott Laboratories as R2.

Browse Market Data Tables and In-Depth TOC of the Rosuvastatin Calcium Market to 2023 @ https://www.researchcosmos.com/reports/global-rosuvastatin-calcium-market-trends-competitive-dynamics-and-key-growth-opportuniti/2056229158

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

Request Free Sample @ https://www.researchcosmos.com/request/2056229158

Market Segment as follows:

By Region / Countries
• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain etc)
• South America (Brazil, Argentina etc)
• Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
• Purity 98.0%
• Purity 99.0%
• Others

By End-User / Application
• Tablet (including dispersible tablet and general tablet)
• Capsule
• Others

By Company
• AstraZeneca
• Teva Pharmaceutical Industries
• MSN Laboratories
• Cadila Pharmaceuticals
• LGM Pharma
• BalPharma
• Changzhou Pharmaceutical Factory
• Jingxin Pharm
• Zhejiang Hisun Pharmaceutical
• HEC Pharm
• Lunan Pharmaceutical
• Nanjing Frochem Tech
• Lianyungang Runzhong Pharmaceutical

Inquire before buying @ https://www.researchcosmos.com/inquire/2056229158

About Us:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

Contact Us:
Dani Rodriguez
Research Cosmos
+1 888 709 8757
dani@researchcosmos.com <||>rnhttps://www.researchcosmos.com




Research Cosmos

Dani Rodriguez

+1 888 709 8757

dani@researchcosmos.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News

[CaRP] XML error: EntityRef: expecting ';' at line 51 - This appears to be an HTML webpage, not a feed.

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com ™ - Medicl Newswire and Press Release service of GroupWeb Media LLC